Abstract
Stool culture for Clostridium difficile, while necessary for strain typing and antimicrobial surveillance, cannot determine toxin production. We prospectively tested in triplicate 91 C difficile cultured isolates for toxin production by 2 enzyme immunoassays (EIAs) (Meridian Premier Toxins A&B, Meridian Bioscience, Cincinnati, OH; and TechLab Tox A/B II, TechLab, Blacksburg, VA) and cytotoxin neutralization bioassay (CTN). By CTN, 88% (80/91) were toxigenic. Reproducibility was 93%(85/91) for CTN, 80% (73/91) for Meridian EIA, and 79% (72/91) for TechLab EIA. Compared with CTN, sensitivities were 87.1% and 89.2% for the Meridian and TechLab EIAs, respectively. In an additional 115 stool specimens, CTN detected toxin more frequently from cultured isolates (96/115) than stool (84/115). For C difficile toxin detection from isolates, EIA was less reproducible than CTN. EIA methods can be falsely negative in 10% to 12% of isolates, and these should be tested by CTN or polymerase chain reaction. When positive, EIA is fast and reliable for detecting C difficile toxin from culture. © American Society for Clinical Pathology.
Author supplied keywords
Cite
CITATION STYLE
She, R. C., Durrant, R. J., & Petti, C. A. (2009). Evaluation of enzyme immunoassays to detect clostridium Difficile toxin from anaerobic stool culture. American Journal of Clinical Pathology, 131(1), 81–84. https://doi.org/10.1309/AJCPMM2E7VSPHNPG
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.